Global Immunodiagnostics Market - Trends Analysis & Forecasts to 2022

Immunodiagnostics Market

Opportunities and Forecasts, 2014 – 2022

Published Date: Nov 2016

No of Pages: 150

IMMUNODIAGNOSTICS MARKET OVERVIEW • Global Immunodiagnostics Market would reach $17,836 Million by 2022, growing at a CAGR of 7.3% from 2016 to 2022, accordingly new report published by Allied Market Research.

• Reagents and consumables is expected to dominate the world immunodiagnostics market throughout the forecast period.

• North America would continue to lead during the forecast period, accounting for more than one-third share of the world immunodiagnostics market in 2015.

• Rise in incidence of infectious diseases one of the most common disease burden globally mainly drives the market. Growth in baby boomer generation with high-risk of targeted diseases and increase in adoption of next generation immunodiagnostics platform propels the market growth.

Read more on:- https://www.alliedmarketresearch.com/immunodiagnostics-market

IMMUNODIAGNOSTICS MARKET OVERVIEW •

Rise in focus of the key players toward innovative immunodiagnostics technologies (such as automated systems, laboratory integrated customized system, and point of care testing among others), along with the growth in immunodiagnostics labs further drives the market growth.

•

However, stringent government regulations, high cost of the sophisticated immunodiagnostics testing such as analyzers and assays, reluctance to adopt newer technology in emerging economies restrain the market growth.

•

Infectious diseases (such as hepatitis, retrovirus, HIV, dengue fever, malaria, and others) is a leading segment in the immunodiagnostics application market accounted for over onefifth of total share in 2015.

•

Owing to diversified use of immunodiagnostics devices in the diagnosis of varied infectious diseases with lower risk followed by quick, reliable, and high success rate has favored its growth in infectious diseases market.

IMMUNODIAGNOSTICS MARKET KEY FINDINGS •

In 2015, reagents and consumables was the leading product type, and is projected to grow at a CAGR of 8.1% during the forecast period.

•

CLIA is expected to grow at a remarkable CAGR of 8.0%, owing to the non-radioactive nature, high sensitivity, and simple equipment designed for well-equipped clinical laboratories.

•

Oncology & endocrinology application is projected to grow at a high CAGR of 8.1% during the analysis period.

•

U.S. alone contributes over three-fourth market share in the North America region of immunodiagnostics market in 2015.

•

China is the major shareholder in the Asia-Pacific region accounting for around one-third of the Asia-Pacific immunodiagnostics market.

•

North America is expected to dominate the immunodiagnostics market followed by Europe, during the analysis period.

KEY BENEFITS OF IMMUNODIAGNOSTICS MARKET  The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets.  The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.  Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.  Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.  Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.

KEY PLAYERS IN INDUSTRY

• • • • • • • • • • •

Abbott Laboratories Immunodiagnostic Systems Holdings Plc (IDS) DiaSorin S.p.A. Johnson & Johnson F. Hoffmann-La Roche Ltd Siemens AG Sysmex Corporation Danaher Corporation Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Arkray Inc.

Get sample report at:- https://www.alliedmarketresearch.com/request-free-sample/1763

KEY DRIVERS OF IMMUNODIAGNOSTICS MARKET

IMMUNODIAGNOSTICS MARKET SEGMENTATION

IMMUNODIAGNOSTICS MARKET BY REGION

North America, Europe, Asia-Pacific, LAMEA

DEFIBRILLATORS MARKET

Enzyme-Linked Immunosorbent Assay (ELISA) is highly preferred technology due to its minimal invasive nature and is designated as �˜gold standard of clinical immunodiagnostics modality for diagnosing various diseases. Despite numerous advancement in the immunodiagnostics field, ELISA will maintain lead due to its high precision, sensitivity, specificity, and throughput as compared to others at economical cost.

Garima Chandra

Thank You!

For More Details Visit us at https://www.alliedmarketresearch.com/immunodiagnostic s-market

Follow Us On